Evidence map›Paper›PMID 26557721›Full record

ReviewJournal of immunology research2015

HTLV-1 ORF-I Encoded Proteins and the Regulation of Host Immune Response: Viral Induced Dysregulation of Intracellular Signaling.

Carolina Rosadas, Marzia Puccioni-Sohler

Abstract readReview
In one paragraph

Review in Journal of immunology research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Possible Trace of HTLV-1 Virus in Modulation of Cbl-b, ITCH, and PP2A Suppressor Genes.International journal of molecular and cellular medicine · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Carolina RosadasUniversidade Federal do Rio de Janeiro (UFRJ), Rua Rodolpho Paulo Rocco 255, 3° Andar, Cidade Universitária, Ilha do Fundão, 21941-913 Rio de Janeiro, RJ, Brazil.
Marzia Puccioni-SohlerUniversidade Federal do Rio de Janeiro (UFRJ), Rua Rodolpho Paulo Rocco 255, 3° Andar, Cidade Universitária, Ilha do Fundão, 21941-913 Rio de Janeiro, RJ, Brazil ; Universidade Federal do Estado do Rio de Janeiro (UNIRIO), Rua Mariz e Barros 775, Tijuca, 20270-901 Rio de Janeiro, RJ, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus associated with both proliferative and inflammatory disorders. This virus causes a persistent infection, mainly in CD4+ T lymphocyte. The ability to persist in the host is associated with the virus capacity to evade the immune response and to induce infected T-cell proliferation, once the HTLV-1 maintains the infection mainly by clonal expansion of infected cells. There are several evidences that ORF-I encoded proteins, such as p12 and p8, play an important role in this context. The present study will review the molecular mechanisms that HTLV-1 ORF-I encoded proteins have to induce dysregulation of intracellular signaling, in order to escape from immune response and to increase the infected T-cell proliferation rate. The work will also address the impact of ORF-I mutations on the human host and perspectives in this study field.

Indexed as

Immune EvasionSignal TransductionAnimalsCD4-Positive T-LymphocytesCell ProliferationHost-Pathogen InteractionsHumansHuman T-lymphotropic virus 1Intracellular Signaling Peptides and ProteinsKiller Cells, NaturalLymphocyte ActivationMutationT-LymphocytesT-Lymphocytes, CytotoxicViral Regulatory and Accessory ProteinsIntracellular Signaling Peptides and Proteinsp12I protein, Human T-lymphotropic virus 1Viral Regulatory and Accessory Proteins

Identifiers

PMID26557721
PMCPMC4628651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.